EUVIMEDEUVIMED entdecken
Crossref

Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness

Amanda Barrow, Cathren Cohen, Jaclyn Serpico, Melissa Goodman, Daniel Grossman, Sarah Raifman, Ushma Upadhyay

Perspectives on Sexual and Reproductive Health · 2024

DOI: 10.1111/psrh.12282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perspectives on Sexual and Reproductive Health, 2024. Verfasst von Amanda Barrow und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center on Reproductive Health, Law, and Policy, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Mifepristone, United States Food and Drug Administration, Abortion, Induced, Abortifacient Agents, Steroidal. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On January 30, 2024, over 300 researchers filed an amicus brief in FDA v. Alliance for Hippocratic Medicine , a United States (US) Supreme Court case concerning the regulatory status of mifepristone, one of two drugs used in medication abortion. In this Comment we summarize the legal challenge, responses from the FDA and drug manufacturer to these challenges, oral arguments presented before the Court, and the implications of the Court's decision on access to mifepristone in the US. We also summarize the content of the accompanying amicus brief.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MifepristoneUnited States Food and Drug AdministrationAbortion, InducedAbortifacient Agents, SteroidalHumansUnited StatesFemalePregnancyReproductive HealthSupreme Court Decisions

Stichwörter der Autor:innen

Food and Drug Administrationabortionlaw/legal issuesmedication abortionpolicy

Substanzen

MifepristoneAbortifacient Agents, Steroidal

Autor:innen und Institutionen

  • Center on Reproductive Health, Law, and Policy, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California San Francisco, Advancing New Standards in Reproductive Health, Oakland, California, USA.

Zitieren

APA

Barrow, A., Cohen, C., Serpico, J., Goodman, M., Grossman, D., Raifman, S., & Upadhyay, U. (2024). Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness. Perspectives on Sexual and Reproductive Health. https://doi.org/10.1111/psrh.12282

Vancouver

Barrow A, Cohen C, Serpico J, Goodman M, Grossman D, Raifman S, et al. Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness. Perspectives on Sexual and Reproductive Health. 2024. doi:10.1111/psrh.12282

BibTeX
@article{Barrow2024,
  author = {Barrow, Amanda and Cohen, Cathren and Serpico, Jaclyn and Goodman, Melissa and Grossman, Daniel and Raifman, Sarah and Upadhyay, Ushma},
  title = {Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness},
  journal = {Perspectives on Sexual and Reproductive Health},
  year = {2024},
  doi = {10.1111/psrh.12282}
}
Kostenlos starten →